Interact to see
Advertisement
Advertisement
JVMTX vs TRTZX
JVMTX vs TRTZX Comparison
Open Charts JVMTX vs TRTZX
JHancock Disciplined Value Mid Cap R4
Price$28.72
Change+$0.08 (+0.28%)
VolumeN/A
Net Assets22.24B
T. Rowe Price Mid-Cap Value Z
Price$31.77
Change+$0.09 (+0.28%)
VolumeN/A
Net Assets15.12B
JVMTX vs TRTZX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
VS
FUNDAMENTALS
Fundamentals
JVMTX has more cash in the bank: 22.2B vs. TRTZX (15.1B). TRTZX pays higher dividends than JVMTX: TRTZX (2.01) vs JVMTX (0.65). JVMTX was incepted earlier than TRTZX: JVMTX (12 years) vs TRTZX (5 years). JVMTX (1.11) is less costly to investors than TRTZX (0.69). TRTZX is a more actively managed with annual turnover of: 52.90 vs. JVMTX (49.00). JVMTX (0) and TRTZX (0) have matching initial minimum investment requirements. JVMTX annual gain was more profitable for investors over the last year : -3.72 vs. TRTZX (-10.00). JVMTX return over 5 years is better than : 54.11 vs. TRTZX (32.52).
| JVMTX | TRTZX | JVMTX / TRTZX | |
| Total Expense Ratio | 1.00 | 0.05 | 2,000% |
| Annual Report Gross Expense Ratio | 1.11 | 0.69 | 161% |
| Fund Existence | 12 years | 5 years | - |
| Gain YTD | 6.429 | -0.907 | -709% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 22.2B | 15.1B | 147% |
| Annual Yield % from dividends | 0.65 | 2.01 | 32% |
| Returns for 1 year | -3.72 | -10.00 | 37% |
| Returns for 3 years | 21.93 | 10.30 | 213% |
| Returns for 5 years | 54.11 | 32.52 | 166% |
| Returns for 10 years | 42.61 | N/A | - |
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| SAGP | 32.89 | 0.16 | +0.49% |
| Strategas Global Policy Opp ETF | |||
| IWB | 343.04 | 1.27 | +0.37% |
| iShares Russell 1000 ETF | |||
| TOK | 126.70 | 0.32 | +0.25% |
| iShares MSCI Kokusai ETF | |||
| FFC | 16.50 | N/A | N/A |
| Flaherty & Crumrine Preferred and Income Securities Fund | |||
| BIS | 15.96 | -0.57 | -3.45% |
| ProShares UltraShort Nasdaq Biotech | |||